EUVIMEDEUVIMED entdecken
Crossref

The “purfling sign”: a new imaging marker for the diagnosis of primary CNS lymphoma

Lei Niu, Jiping Zhao, Chongfeng Duan, Weiwei Fu, Yingchao Liu, Xuejun Liu, Shuangshuang Song

La radiologia medica · 12.05.2025 · 130 (7) · 1115-1123

DOI: 10.1007/s11547-025-01970-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift La radiologia medica, online erschienen am 12.05.2025. Verfasst von Lei Niu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People's Republic of China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Lymphoma, Central Nervous System Neoplasms, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Qingdao Postdoctoral Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To investigate whether the "purfling sign," a new imaging marker, could distinguish primary central nervous system lymphoma (PCNSL) from brain gliomas, and its diagnosis value for preoperative identification of PCNSL. METHODS: Contrast-enhanced MR imaging features of 161 PCNSL and 161 glioma were evaluated by 2 independent neuroradiologists: (1) the presence/absence of the "purfling sign"; (2) the presence/absence of lesion necrosis and cystic changes; and (3) the heterogeneity of tumor parenchymal enhancement. Inter-rater agreement was assessed with Cohen's kappa (κ), and the diagnostic performance of the "purfling sign" in identifying PCNSL was investigated. Three separate institutional validation cohort (including 177 PCNSL and 177 glioma patients) was analyzed to validate the diagnostic performance of the "purfling sign." RESULTS: Among the test set, the inter-rater agreement of the "purfling sign" was high (κ = 0.907), while that for the other features was only good [κ = 0.663-0.691]. The purfling sign was present in 89 (55.28%) lymphoma and 13 (8.07%) glioma cases with a specificity of 91.93%, a sensitivity of 55.28%, a positive predictive value (PPV) of 87.25%, and a negative predictive value (NPV) of 67.27% for the diagnosis of PCNSL. Furthermore, the tumors presenting with the "target sign" were all PCNSL (16/16,100%), with a specificity and PPV of 100%. Analysis with the validation cohort, 85.09% cases with a positive "purfling sign" were PCNSL (p < 0.0001; PPV = 85.09%, NPV = 66.67%, specificity = 90.40%, sensitivity = 54.80%). CONCLUSIONS: With a robust inter-rater agreement, our study found that the "purfling sign" on enhanced MR represents a high specific imaging marker for the preoperative diagnosis of PCNSL. This noninvasive marker may aid in the guidance of the clinical diagnosis and treatment processes of PCNSL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingLymphomaCentral Nervous System NeoplasmsBrain NeoplasmsGliomaHumansMaleFemaleMiddle AgedDiagnosis, DifferentialContrast MediaAgedAdultRetrospective StudiesSensitivity and SpecificityAged, 80 and over

Stichwörter der Autor:innen

Enhanced MRImaging markerPrimary central nervous system lymphomaPurfling sign

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People's Republic of China.
  • Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao266003, People's Republic of China.
  • Department of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, People's Republic of China.
  • Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People's Republic of China. dr.liuxuejun@qdu.edu.cn.
  • Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People's Republic of China. song2222shuang@163.com.
  • Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266100, People's Republic of China. song2222shuang@163.com.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Qingdao Postdoctoral Project

Zitieren

APA

Niu, L., Zhao, J., Duan, C., Fu, W., Liu, Y., Liu, X., & Song, S. (2025). The “purfling sign”: a new imaging marker for the diagnosis of primary CNS lymphoma. La radiologia medica, 130(7), 1115-1123. https://doi.org/10.1007/s11547-025-01970-8

Vancouver

Niu L, Zhao J, Duan C, Fu W, Liu Y, Liu X, et al. The “purfling sign”: a new imaging marker for the diagnosis of primary CNS lymphoma. La radiologia medica. 2025;130(7):1115-1123. doi:10.1007/s11547-025-01970-8

BibTeX
@article{Niu2025,
  author = {Niu, Lei and Zhao, Jiping and Duan, Chongfeng and Fu, Weiwei and Liu, Yingchao and Liu, Xuejun and Song, Shuangshuang},
  title = {The “purfling sign”: a new imaging marker for the diagnosis of primary CNS lymphoma},
  journal = {La radiologia medica},
  year = {2025},
  volume = {130},
  number = {7},
  pages = {1115--1123},
  doi = {10.1007/s11547-025-01970-8}
}
Kostenlos starten →